The Paclitaxel Paradox: Physicians Hold Steady Despite SWEDEPAD Setbacks
Despite trials failing to support the impact of paclitaxel-coated balloons and stents on key peripheral arterial disease endpoints, almost half of physicians do not intend to change their use patterns for paclitaxel-coated devices.